(Q34314044)

1 August 2017

1 reference

title

First-line treatment of hypertension: from monotherapy to fixed low-dose combination therapy (English)

1 reference

1 August 2017

Piot O

1

1 reference

1 August 2017

Gallois H

series ordinal

2

1 reference

1 August 2017

Baguet JP

series ordinal

3

1 reference

1 August 2017

Mallion JM

series ordinal

4

1 reference

1 August 2017

language of work or name

1 reference

1 July 2001

1 reference

Journal of Human Hypertension

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

443-446

1 reference

Blood pressure screening, management and control in England

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Prevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

The BBB Study: the effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in "well-treated" hypertensive patients. Behandla Blodtryck Bättre

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Follow-up study of the use of antihypertensive drug treatment and of the population treated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

The use of free and fixed drug combinations to improve hypertension control in our populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Results of hypertension treatment with low-dose combinations of a beta-adrenergic blocker and a diuretic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001204

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001204

1 reference

Dimensions Publication ID

1 August 2017

1031748686

0 references

1 reference